Further, GSEA of the signature score indicated that samples with high scores were mainly enriched in IL6/JAK/SATA3 signaling, complement, and allograft rejection, indicating HNSCC patients with poor prognosis might have dysfunctional immune systems. Here, IL6 is linked to head and neck squamous cell carcinoma.